Variables
|
Men
|
Women
|
---|
|
Carotid atherosclerosis (−); n = 1245
|
Carotid atherosclerosis (+); n = 247
|
P-value
|
Carotid atherosclerosis (−); n = 309
|
Carotid atherosclerosis (+); n = 62
|
P-value
|
---|
Age (ys)
|
45.14 ± 0.23
|
53.95 ± 0.58
|
<0.001
|
49.61 ± 0.50
|
58.47 ± 1.17
|
<0.001
|
SBP (mm Hg)
|
137.83 ± 0.31
|
142.69 ± 1.01
|
<0.001
|
137.28 ± 0.61
|
142.52 ± 1.55
|
<0.001
|
DBP (mm Hg)
|
80.10 ± 0.27
|
90.16 ± 0.73
|
<0.001
|
86.40 ± 0.53
|
88.53 ± 1.39
|
<0.001
|
BMI (kg/m2)
|
25.75 ± 0.08
|
25.63 ± 0.17
|
0.544
|
24.26 ± 0.17
|
25.23 ± 0.39
|
0.021
|
FPG (mmol/L)
|
5.70 ± 0.03
|
5.96 ± 0.10
|
0.016
|
5.62 ± 0.06
|
5.65 ± 0.09
|
0.848
|
FINS (pmol/L)
|
70.01 ± 1.10
|
60.49 ± 2.21
|
<0.001
|
62.99 ± 1.75
|
72.06 ± 4.63
|
0.041
|
HOMA-IR
|
2.58 ± 0.05
|
2.34 ± 0.11
|
0.034
|
2.28 ± 0.07
|
2.62 ± 0.18
|
0.056
|
TC (mmol/L)
|
5.28 ± 0.03
|
5.46 ± 0.06
|
0.007
|
5.38 ± 0.05
|
5.74 ± 0.12
|
0.005
|
HDL-C (mmol/L)
|
1.36 ± 0.01
|
1.38 ± 0.02
|
0.284
|
1.64 ± 0.02
|
1.53 ± 0.04
|
0.01
|
non-HDL-C/HDL-C
|
2.97 ± 0.02
|
3.06 ± 0.06
|
0.149
|
2.37 ± 0.04
|
2.82 ± 0.08
|
<0.001
|
LDL-C (mmol/L)
|
3.44 ± 0.02
|
3.55 ± 0.05
|
0.041
|
3.29 ± 0.04
|
3.65 ± 0.09
|
0.001
|
TG (mmol/L)
|
2.31 ± 0.04
|
2.13 ± 0.08
|
0.054
|
1.72 ± 0.04
|
2.14 ± 0.13
|
<0.001
|
ApoAΙ (g/L)
|
1.38 ± 0.01
|
1.40 ± 0.01
|
0.321
|
1.54 ± 0.01
|
1.51 ± 0.02
|
0.26
|
ApoB (g/L)
|
1.17 ± 0.01
|
1.25 ± 0.02
|
<0.001
|
1.13 ± 0.02
|
1.27 ± 0.04
|
0.001
|
ApoB/apoAΙ
|
0.85 ± 0.01
|
0.91 ± 0.02
|
0.001
|
0.75 ± 0.01
|
0.85 ± 0.03
|
0.001
|
CRP (mg/L)
|
5.35 ± 0.12
|
5.67 ± 0.48
|
0.363
|
5.34 ± 0.21
|
4.57 ± 0.35
|
0.117
|
HCY (μmol/L)
|
11.16 ± 0.15
|
11.6 ± 0.29
|
0.186
|
8.28 ± 0.18
|
9.76 ± 0.38
|
0.001
|
GGT (U/L)
|
61.54 ± 1.60
|
54.47 ± 3.72
|
0.074
|
23.69 ± 1.13
|
30.95 ± 3.86
|
0.075
|
UA (μmol/L)
|
371.29 ± 2.15
|
360.94 ± 4.51
|
0.048
|
257.46 ± 3.07
|
283.81 ± 7.56
|
0.001
|
Current smoker(%)
|
41.5
|
39.7
|
>0.05
|
0.6
|
0
|
>0.05
|
- SBP: systolic blood pressure; DBP: diastolic blood pressure; BMI: body mass index; FPG: fasting plasma glucose; FINS: fasting insulin; HOMA-IR: homeostasis model assessment of insulin resistance; TC: total cholesterol; HDL-C: high density lipoprotein cholesterol; LDL-C: low density lipoprotein cholesterol; non-HDL-C: non-high density lipoprotein cholesterol; TG: triglycerides; ApoAΙ: apolipoprotein AΙ; ApoB: apolipoprotein B; CRP: C-reactive protein; HCY: Homocysteine; GGT: gamma-glutamyl transpeptidase; UA: uric acid; Carotid atherosclerosis(+): CIMT was ≥ 0.9 mm; Carotid atherosclerosis(−): CIMT was < 0.9 mm.